BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37321394)

  • 1. The association of female sex with management and mortality in patients with Staphylococcus aureus bacteraemia.
    Westgeest AC; Ruffin F; Kair JL; Park LP; Korn RE; Webster ME; Visser LG; Schippers EF; de Boer MGJ; Lambregts MMC; Fowler VG
    Clin Microbiol Infect; 2023 Sep; 29(9):1182-1187. PubMed ID: 37321394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical predictors of methicillin-resistance and their impact on mortality associated with Staphylococcus aureus bacteraemia.
    Wi YM; Rhee JY; Kang CI; Chung DR; Song JH; Peck KR
    Epidemiol Infect; 2018 Jul; 146(10):1326-1336. PubMed ID: 29781425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
    Yaw LK; Robinson JO; Ho KM
    Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.
    Cuervo G; Camoez M; Shaw E; Dominguez MÁ; Gasch O; Padilla B; Pintado V; Almirante B; Molina J; López-Medrano F; Ruiz de Gopegui E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MÁ; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    BMC Infect Dis; 2015 Oct; 15():484. PubMed ID: 26518487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
    Robinson JO; Phillips M; Christiansen KJ; Pearson JC; Coombs GW; Murray RJ
    Clin Microbiol Infect; 2014 Jun; 20(6):530-5. PubMed ID: 24224545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
    Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
    Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients.
    Tumbarello M; de Gaetano Donati K; Tacconelli E; Citton R; Spanu T; Leone F; Fadda G; Cauda R
    J Antimicrob Chemother; 2002 Sep; 50(3):375-82. PubMed ID: 12205062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.
    Ho KM; Robinson JO
    Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge.
    Wolkewitz M; Frank U; Philips G; Schumacher M; Davey P;
    J Antimicrob Chemother; 2011 Feb; 66(2):381-6. PubMed ID: 21098543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
    Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
    J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
    Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
    Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients.
    Wang JL; Lai CH; Lin HH; Chen WF; Shih YC; Hung CH
    Int J Antimicrob Agents; 2013 Nov; 42(5):390-4. PubMed ID: 24041465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Kim SH; Park WB; Lee KD; Kang CI; Bang JW; Kim HB; Kim EC; Oh MD; Choe KW
    J Antimicrob Chemother; 2004 Aug; 54(2):489-97. PubMed ID: 15254028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia.
    Siméon S; Le Moing V; Tubiana S; Duval X; Fournier D; Lavigne JP; Erpelding ML; Gustave CA; Desage S; Chirouze C; Vandenesch F; Tattevin P;
    Clin Microbiol Infect; 2019 Apr; 25(4):481-488. PubMed ID: 30036664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study.
    Kuehl R; Morata L; Boeing C; Subirana I; Seifert H; Rieg S; Kern WV; Kim HB; Kim ES; Liao CH; Tilley R; Lopez-Cortés LE; Llewelyn MJ; Fowler VG; Thwaites G; Cisneros JM; Scarborough M; Nsutebu E; Gurgui Ferrer M; Pérez JL; Barlow G; Hopkins S; Ternavasio-de la Vega HG; Török ME; Wilson P; Kaasch AJ; Soriano A;
    Lancet Infect Dis; 2020 Dec; 20(12):1409-1417. PubMed ID: 32763194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus.
    Park KH; Kim ES; Kim HS; Park SJ; Bang KM; Park HJ; Park SY; Moon SM; Chong YP; Kim SH; Lee SO; Choi SH; Jeong JY; Kim MN; Woo JH; Kim YS
    J Antimicrob Chemother; 2012 Aug; 67(8):1843-9. PubMed ID: 22535621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do the epidemiology of paediatric methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus bacteraemia differ?
    Abernethy J; Sharland M; Johnson AP; Hope R
    J Med Microbiol; 2017 Jun; 66(6):737-743. PubMed ID: 28598316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa.
    Fortuin-de Smidt MC; Singh-Moodley A; Badat R; Quan V; Kularatne R; Nana T; Lekalakala R; Govender NP; Perovic O;
    Int J Infect Dis; 2015 Jan; 30():41-8. PubMed ID: 25448331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.